If cognitive symptoms are severe, persistent, or interfere with daily activities, contact your GP or diabetes care team for assessment
Metabolism and action of L-carnitine: its possible role in sperm tail function
GLP-1 Pipeline Update: November 2024 Quarterly view of the GLP-1 pipeline and anticipated indications Editorial team Maryam Tabatabai, PharmD Editor-In-Chief Vice President, Clinical Information Carole Kerzic, RPh Executive Editor Clinical Pharmacist, Drug Information Nicole Kjesbo, PharmD, BCPS Executive Editor Clinical Program Director, Pipeline Lisa Schweizer, PharmD, JD Director, Clinical Program Management Deputy Editor DISCLAIMER The drug pipeline is fluid
Individual factors such as previous tolerance, experienced side effects, and overall health status will influence the restart strategy
26.8%, P=0.086) (Table 2)
Research Here are some reputable websites and research articles that explain the downsides of Semaglutide Tirzepatideand other GLP-1 medications for weight loss: National Institutes of Health (NIH) GLP-1 receptor agonists: effects on appetite and body weight in patients with type 2 diabetes This article provides an overview of the effects of GLP-1 receptor agonists on appetite and body weight, discussing both benefits and potential side effects